Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment

Saved in:

Bibliographic Details
Published in:	Ther Adv Neurol Disord
Main Authors:	Manouchehri, Navid, Stüve, Olaf
Format:	Artigo
Language:	Inglês
Published:	SAGE Publications 2021
Subjects:	Letter to the Editor
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7970673/ https://ncbi.nlm.nih.gov/pubmed/33796142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286421990500
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items